111 related articles for article (PubMed ID: 11561149)
1. A genetically modified adenoviral vector exhibits enhanced gene transfer of human smooth muscle cells.
Su EJ; Stevenson SC; Rollence M; Marshall-Neff J; Liau G
J Vasc Res; 2001; 38(5):471-8. PubMed ID: 11561149
[TBL] [Abstract][Full Text] [Related]
2. Enhanced gene transfer to rabbit jugular veins by an adenovirus containing a cyclic RGD motif in the HI loop of the fiber knob.
Hay CM; De Leon H; Jafari JD; Jakubczak JL; Mech CA; Hallenbeck PL; Powell SK; Liau G; Stevenson SC
J Vasc Res; 2001; 38(4):315-23. PubMed ID: 11455202
[TBL] [Abstract][Full Text] [Related]
3. Efficient adenoviral gene transfer to kidney cortical vasculature utilizing a fiber modified vector.
McDonald GA; Zhu G; Li Y; Kovesdi I; Wickham TJ; Sukhatme VP
J Gene Med; 1999; 1(2):103-10. PubMed ID: 10738574
[TBL] [Abstract][Full Text] [Related]
4. Optimizing cardiovascular gene therapy: increased vascular gene transfer with modified adenoviral vectors.
Kibbe MR; Murdock A; Wickham T; Lizonova A; Kovesdi I; Nie S; Shears L; Billiar TR; Tzeng E
Arch Surg; 2000 Feb; 135(2):191-7. PubMed ID: 10668880
[TBL] [Abstract][Full Text] [Related]
5. In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries.
Lee SW; Trapnell BC; Rade JJ; Virmani R; Dichek DA
Circ Res; 1993 Nov; 73(5):797-807. PubMed ID: 8403251
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of adenoviral vector-mediated gene delivery to vascular smooth muscle cells: modulation by poloxamer 407 and implications for cardiovascular gene therapy.
March KL; Madison JE; Trapnell BC
Hum Gene Ther; 1995 Jan; 6(1):41-53. PubMed ID: 7703286
[TBL] [Abstract][Full Text] [Related]
7. Arterial gene transfer to rabbit endothelial and smooth muscle cells using percutaneous delivery of an adenoviral vector.
Steg PG; Feldman LJ; Scoazec JY; Tahlil O; Barry JJ; Boulechfar S; Ragot T; Isner JM; Perricaudet M
Circulation; 1994 Oct; 90(4):1648-56. PubMed ID: 7923648
[TBL] [Abstract][Full Text] [Related]
8. Cationic liposomes enhance adenovirus entry via a pathway independent of the fiber receptor and alpha(v)-integrins.
Qiu C; De Young MB; Finn A; Dichek DA
Hum Gene Ther; 1998 Mar; 9(4):507-20. PubMed ID: 9525312
[TBL] [Abstract][Full Text] [Related]
9. Fetal muscle gene transfer is not enhanced by an RGD capsid modification to high-capacity adenoviral vectors.
Bilbao R; Reay DP; Hughes T; Biermann V; Volpers C; Goldberg L; Bergelson J; Kochanek S; Clemens PR
Gene Ther; 2003 Oct; 10(21):1821-9. PubMed ID: 12960972
[TBL] [Abstract][Full Text] [Related]
10. Targeting of high-capacity adenoviral vectors.
Biermann V; Volpers C; Hussmann S; Stock A; Kewes H; Schiedner G; Herrmann A; Kochanek S
Hum Gene Ther; 2001 Sep; 12(14):1757-69. PubMed ID: 11560769
[TBL] [Abstract][Full Text] [Related]
11. Comparison between recombinant baculo- and adenoviral-vectors as transfer system in cardiovascular cells.
Grassi G; Köhn H; Dapas B; Farra R; Platz J; Engel S; Cjsareck S; Kandolf R; Teutsch C; Klima R; Triolo G; Kuhn A
Arch Virol; 2006 Feb; 151(2):255-71. PubMed ID: 16195789
[TBL] [Abstract][Full Text] [Related]
12. Improved vascular gene transfer with a helper-dependent adenoviral vector.
Wen S; Graf S; Massey PG; Dichek DA
Circulation; 2004 Sep; 110(11):1484-91. PubMed ID: 15326058
[TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro gene transfer and expression in rat intestinal epithelial cells by E1-deleted adenoviral vector.
Cheng DY; Kolls JK; Lei D; Noel RA
Hum Gene Ther; 1997 Apr; 8(6):755-64. PubMed ID: 9113515
[TBL] [Abstract][Full Text] [Related]
14. Improved adenoviral vector for vascular gene therapy : beneficial effects on vascular function and inflammation.
Qian HS; Channon K; Neplioueva V; Wang Q; Finer M; Tsui L; George SE; McArthur J
Circ Res; 2001 May; 88(9):911-7. PubMed ID: 11349000
[TBL] [Abstract][Full Text] [Related]
15. Influence of temperature on adenovirus-mediated gene transfer.
Pellegrini C; O'Brien T; Jeppsson A; Fitzpatrick LA; Yap J; Tazelaar HD; McGregor CG
Eur J Cardiothorac Surg; 1998 May; 13(5):599-603. PubMed ID: 9663545
[TBL] [Abstract][Full Text] [Related]
16. Development of efficient viral vectors selective for vascular smooth muscle cells.
Work LM; Nicklin SA; Brain NJ; Dishart KL; Von Seggern DJ; Hallek M; Büning H; Baker AH
Mol Ther; 2004 Feb; 9(2):198-208. PubMed ID: 14759804
[TBL] [Abstract][Full Text] [Related]
17. Localized adenovirus gene delivery using antiviral IgG complexation.
Levy RJ; Song C; Tallapragada S; DeFelice S; Hinson JT; Vyavahare N; Connolly J; Ryan K; Li Q
Gene Ther; 2001 May; 8(9):659-67. PubMed ID: 11406760
[TBL] [Abstract][Full Text] [Related]
18. Modifications in adenoviral coat fiber proteins and transcriptional regulatory sequences enhance transgene expression.
Perlman H; Liu H; Georganas C; Woods JM; Amin MA; Koch AE; Wickham T; Kovesdi I; Mano T; Walsh K; Pope RM
J Rheumatol; 2002 Aug; 29(8):1593-600. PubMed ID: 12180715
[TBL] [Abstract][Full Text] [Related]
19. Adeno-associated virus vectors for vascular gene delivery.
Lynch CM; Hara PS; Leonard JC; Williams JK; Dean RH; Geary RL
Circ Res; 1997 Apr; 80(4):497-505. PubMed ID: 9118480
[TBL] [Abstract][Full Text] [Related]
20. Helper-dependent adenoviral vectors containing modified fiber for improved transduction of developing and mature muscle cells.
Bramson JL; Grinshtein N; Meulenbroek RA; Lunde J; Kottachchi D; Lorimer IA; Jasmin BJ; Parks RJ
Hum Gene Ther; 2004 Feb; 15(2):179-88. PubMed ID: 14975190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
